S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
S&P 500   0.64 (+1.11%)
DOW   0.64 (+1.11%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

NYSE:PHRPhreesia Stock Price, Forecast & News

$29.31
+1.06 (+3.75 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.01
Now: $29.31
$29.37
50-Day Range
$27.02
MA: $29.11
$32.03
52-Week Range
$16.01
Now: $29.31
$34.85
Volume253,600 shs
Average Volume461,695 shs
Market Capitalization$1.10 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone888-654-7473

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$124.78 million
Book Value$2.84 per share

Profitability

Net Income$-20,290,000.00

Miscellaneous

Employees436
Market Cap$1.10 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive PHR News and Ratings via Email

Sign-up to receive the latest news and ratings for PHR and its competitors with MarketBeat's FREE daily newsletter.

Phreesia (NYSE:PHR) Frequently Asked Questions

How has Phreesia's stock been impacted by COVID-19 (Coronavirus)?

Phreesia's stock was trading at $23.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PHR shares have increased by 24.7% and is now trading at $29.31. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Phreesia?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Phreesia.

How were Phreesia's earnings last quarter?

Phreesia (NYSE:PHR) released its quarterly earnings data on Tuesday, June, 9th. The company reported ($0.16) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.23) by $0.07. The business had revenue of $33.40 million for the quarter, compared to the consensus estimate of $25.92 million. Phreesia had a negative return on equity of 19.36% and a negative net margin of 15.18%. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. View Phreesia's earnings history.

What price target have analysts set for PHR?

12 Wall Street analysts have issued 1 year price objectives for Phreesia's shares. Their forecasts range from $21.00 to $37.00. On average, they anticipate Phreesia's share price to reach $30.64 in the next year. This suggests a possible upside of 4.5% from the stock's current price. View analysts' price targets for Phreesia.

Has Phreesia been receiving favorable news coverage?

Media coverage about PHR stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Phreesia earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Phreesia.

Are investors shorting Phreesia?

Phreesia saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 912,000 shares, an increase of 7.8% from the May 31st total of 846,400 shares. Based on an average trading volume of 475,700 shares, the days-to-cover ratio is currently 1.9 days. Currently, 4.2% of the company's shares are sold short. View Phreesia's Current Options Chain.

Who are some of Phreesia's key competitors?

What other stocks do shareholders of Phreesia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Zscaler (ZS), Fastly (FSLY), AT&T (T), Gilead Sciences (GILD), Healthequity (HQY), Okta (OKTA), Shopify (SHOP), Square (SQ), Exxon Mobil (XOM) and AbbVie (ABBV).

Who are Phreesia's key executives?

Phreesia's management team includes the following people:
  • Mr. Chaim Indig, Co-Founder, CEO & Director (Age 41)
  • Mr. Evan Roberts, Co-Founder & COO (Age 40)
  • Mr. Thomas Altier, Chief Financial Officer (Age 69)
  • Mr. Daniel Nathan, Chief Technology Officer (Age 43)
  • Mr. Charles H. N. Kallenbach J.D., Gen. Counsel & Sec. (Age 56)

When did Phreesia IPO?

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

What is Phreesia's stock symbol?

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Who are Phreesia's major shareholders?

Phreesia's stock is owned by a number of retail and institutional investors. Top institutional investors include Legacy Advisors LLC (0.08%). Company insiders that own Phreesia stock include Amy Beth Vanduyn, Chaim Indig, Charles Kallenbach, Daniel Nathan, David Linetsky, Evan Roberts, Gillian Munson, Ii LP Chv, Michael J Davidoff, Michael Weintraub, Polaris Venture Management Co, Scott Perricelli and Thomas Altier. View institutional ownership trends for Phreesia.

Which major investors are buying Phreesia stock?

PHR stock was purchased by a variety of institutional investors in the last quarter, including Legacy Advisors LLC. View insider buying and selling activity for Phreesia.

How do I buy shares of Phreesia?

Shares of PHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Phreesia's stock price today?

One share of PHR stock can currently be purchased for approximately $29.31.

How big of a company is Phreesia?

Phreesia has a market capitalization of $1.10 billion and generates $124.78 million in revenue each year. The company earns $-20,290,000.00 in net income (profit) each year or ($4.50) on an earnings per share basis. Phreesia employs 436 workers across the globe.

What is Phreesia's official website?

The official website for Phreesia is www.phreesia.com.

How can I contact Phreesia?

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The company can be reached via phone at 888-654-7473 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.